Meeting
2019 Best of ASCO Austin
Question and Answer
Presenter
Panel Discussion
American Society of Clinical Oncology
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
General Session
Session Title
Gynecologic Cancer
Track
Special Sessions
Similar Videos & Slides
Videos & Slides
2021 ASCO Annual Meeting
TNB585.001: A multicenter, phase 1, open-label, dose-escalation and expansion study of tnb-585, a bispecific T-cell engager targeting PSMA in subjects with metastatic castrate resistant prostate cancer.
Speaker: Ben Buelow, MD, PhD
Videos & Slides
2021 Genitourinary Cancers Symposium
A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC).
Speaker: Tie Zhou
Speaker: Jiping Wang, MD, PhD
Videos & Slides
2024 ASCO Annual Meeting
A clinical-genetic (CG) circulating tumor DNA (ctDNA)-based prognostic model for predicting overall survival (OS) in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with potent androgen receptor inhibition (Alliance).
Speaker: Susan Halabi, PhD, FASCO